Ledger.Open graph →
SEC Form D · Amendment · filed June 22, 2023

Origin Life Sciences, Inc

Offering
$850K
Sold
$660K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PRINCETON, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

John D. Fernandes · Princeton, NJExecVictor D. Micati · Princeton, NJDirectorAnthony D. Brampton · Princeton, NJDirectorMichael D. Preston · Princeton, NJExec · DirectorJerome B. Korten · Princeton, NJDirectorDavid D. Dantzker · Princeton, NJExec · DirectorChristopher Heymann · George Town, Grand Cayman, Cayman IslandsDirectorJoshua Collinsworth · Essex, VTExec · DirectorKimberly Lewis · Chicago, ILExecLasse Clausen · George Town, Grand Cayman, Cayman IslandsExec · DirectorGiles Swan · Central, Hong KongDirectorLeslie Roland Truelove · Chicago, ILDirectorRyan Sather · Eden Prairie, MNExecScott Kirchner · Eden Prairie, MNDirectorJames R. Rouche · Oklahoma City, OKExec · DirectorChristian Buckley · San Diego, CADirectorAndrew W. Guille · St Peter Port, Y7Exec · DirectorDavid M. Emery · St Peter Port, Y7Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗